Skip to main content
editorial
. 2015 May 15;7(5):30–46. doi: 10.4251/wjgo.v7.i5.30

Table 5.

Epigenetic ↑ or ↓ miRNAs, altered in cancers, targeting DNA repair genes

Specific miRNA DNA repair gene targets Cancers affected (frequency if measured) References indicating epigenetic control of miRNA References indicating target gene(s) of miRNAs References indicating cancer type(s) affected
miR-103 miR-107 RAD51, RAD51D Osteosarcoma, lung, endometrial, stomach [100] [101] [101]
miR-34c UNG Gastric (70%) field defect gastric (27%) colon (98%) field defect colon (60%) chronic lymphocytic leukemia (18%) small-cell lung cancer (67%) NSCLC (26%) [102,104] [103] [102,105,106]
miR-31 PARP1 MLH1 SMUG1 MMS19 Esophagus (47%) colon [72] [21] [71,107,108]
miR-124 KU70 Colon [109] [110] [109]
miR-155 RAD51 MLH1 MSH2 MSH6 Breast Colon [90,111] [23,112] [23,90]
let-7a repression increases HMGA2; HMGA2 alters chromatin architecture of and represses ERCC1) ERCC1 (Colon) Anaplastic astrocytoma [90] [92,113] [113]
Let-7b repression increases HMGA1; HMGA1 targets P53 P53 Prostate Colon [90] [114,115] [114,115]
miR-182 BRCA1 NBN RAD17 Breast Colon [116] [117,118] [107,117,119]